Modern Weight ScienceAbout

Compounded Semaglutide vs. Brand Wegovy: Is It the Same Drug?

MWS

Modern Weight Science Editorial Team

Editorial Team

Published May 20269 min read

Compounded semaglutide contains the same active molecule as Wegovy — but it is not the same product. The distinction between them affects quality assurance, regulatory oversight, legal status, and price. Here is what you need to know.

Compounded semaglutide and brand Wegovy both deliver semaglutide to GLP-1 receptors in your body. From a pharmacological standpoint, the mechanism is the same. From a regulatory, quality, and legal standpoint, they are meaningfully different products — and understanding that distinction helps you make an informed decision about which route makes sense for your situation.

What "compounded" means

Compounding is the preparation of a customised medication by a licensed pharmacy, typically when a commercially available equivalent cannot meet a patient's needs. Compounding pharmacies in the US operate under two frameworks:

  • 503A pharmacies — traditional compounding pharmacies that prepare medications on a patient-specific prescription basis. Subject to state pharmacy board regulation and some federal oversight but not required to meet FDA manufacturing standards.
  • 503B outsourcing facilities — larger facilities that can produce medications in bulk without patient-specific prescriptions, subject to FDA oversight and current Good Manufacturing Practice (cGMP) standards, which are significantly more rigorous than 503A requirements.

Both can legally produce compounded semaglutide. The quality and consistency of their products differs substantially.

What brand Wegovy actually is

Wegovy is a finished pharmaceutical product that has passed through the full FDA approval process: clinical trials demonstrating safety and efficacy, manufacturing facility inspections, standardised formulation, defined stability testing, and ongoing post-market surveillance. Every pen contains a verified quantity of pharmaceutical-grade semaglutide in a consistent formulation.

The key differences

  • FDA approval: Wegovy is FDA-approved as a finished product. Compounded semaglutide is not — the compounding pharmacy is licensed, but the compound itself has not gone through the FDA drug approval process.
  • Manufacturing standards: Wegovy is produced to pharmaceutical GMP. Compounded products vary — 503B is stricter than 503A, but neither meets the same standards as a fully approved manufacturer.
  • Consistency: Wegovy's formulation is identical across every pen. Compounded semaglutide's consistency depends on the specific pharmacy's quality controls.
  • Additives: Some compounded versions include additional ingredients (B12, for example) that are not part of the original semaglutide formulation. The clinical significance of these additions is not established.
  • Price: Compounded semaglutide typically costs $150–$500/month through telehealth providers. Wegovy without insurance runs $1,300+/month, though savings cards can reduce this dramatically for eligible patients.

Compounding of FDA-approved drugs is legally permitted when the branded drug is on the FDA's drug shortage list. Semaglutide was on the shortage list for an extended period, which allowed compounding pharmacies to produce it at scale. As shortage status has changed, the legal landscape for compounded semaglutide has shifted — pharmacies producing it without a valid shortage exemption may face enforcement actions. The situation has been evolving rapidly; verify current legal status with your provider.

Is compounded semaglutide dangerous?

Compounded semaglutide from a reputable, licensed pharmacy has been used by hundreds of thousands of patients with a profile of side effects similar to brand Wegovy. The FDA has raised concerns about quality and consistency at some compounders, and there have been reports of dosing errors and impurity issues at lower-quality facilities. The risk is not uniform across all compounders — it depends heavily on where the product comes from.

How to evaluate a compounded semaglutide provider

  • Ask explicitly which pharmacy fills the prescriptions — 503A or 503B?
  • Check whether the pharmacy has had any FDA warning letters or state board actions
  • Confirm the product does not contain non-standard additives unless your prescriber has specifically indicated these
  • Ensure there is a real licensed prescriber, not just a checkout flow
This article is educational. Whether compounded semaglutide is appropriate, legal to prescribe, and available in your situation depends on current FDA guidance and your prescriber's assessment. Always verify the current regulatory status and pharmacy credentials before starting.

About the author

MWS

Modern Weight Science Editorial Team

Editorial Team

Evidence-based research and educational content focused on metabolism, appetite regulation, and sustainable weight management. Our team synthesizes peer-reviewed research into clear, accessible guidance for informed health decisions.

Metabolic scienceGLP-1 biologyObesity researchAppetite regulationClinical nutrition

Content reviewed against peer-reviewed research. Read our editorial policy →

Last updated May 2026

Frequently Asked Questions

What is the difference between Ozempic and Wegovy?

Both contain semaglutide, but they are FDA-approved for different indications. Ozempic (up to 2mg) is approved for type 2 diabetes management and cardiovascular risk reduction. Wegovy (up to 2.4mg) is approved for chronic weight management. The distinction directly affects insurance coverage, maximum dose, and prescribing eligibility — and the two are not interchangeable through most pharmacies.

Do I need a prescription for semaglutide or tirzepatide?

Yes. Semaglutide and tirzepatide are prescription-only medications in the United States and most countries. They require evaluation and a prescription from a licensed healthcare provider. Compounded versions have been available through telehealth platforms, but these are not FDA-approved and carry different regulatory and quality considerations.

How long does it take to see results on GLP-1 medications?

Appetite changes are typically noticed in weeks 1-2. Meaningful weight loss (5-10% of body weight) generally occurs by weeks 12-20. Clinical trial results are measured at 68-72 weeks. The dose escalation schedule means the first 16-20 weeks are primarily about building tolerance, not maximum efficacy. Individual response varies significantly.

What happens when you stop taking a GLP-1 medication?

Most people regain a significant portion of lost weight within 12 months of stopping. Discontinuation studies show that the compensatory hunger and metabolic changes that GLP-1 medications suppress tend to return when the medication is withdrawn. Many clinicians now frame these as long-term treatments — similar to antihypertensives — rather than short-term interventions.

Not medical advice. This guide is for general education only. GLP-1 medications, dosing, and treatment suitability are decisions for you and a licensed clinician who knows your full medical history.

Partnered Resources·Affiliate disclosure

Treatment Options

Clinically supervised approaches to metabolic health and weight management, evaluated by licensed physicians.

GLP-1 Telehealth

Ro Body

A physician-led telehealth program that evaluates your metabolic health and discusses FDA-cleared medication options where clinically appropriate.

Learn more
Metabolic Health Program

Found

Combines medical evaluation, pharmacotherapy when indicated, and behavioral coaching into a structured, ongoing metabolic health plan.

Learn more
Clinical Weight Program

Calibrate

A year-long metabolic reset built around GLP-1 medication, with physician oversight, registered dietitian support, and behavioral coaching.

Learn more

Affiliate disclosure: Modern Weight Science may earn a commission if you visit or purchase through these links, at no additional cost to you. Programs are listed for educational relevance. This is not a clinical recommendation — always consult a licensed healthcare professional before starting any treatment.

Weekly Digest

Get Evidence-Based Metabolic Health Insights Weekly

Research-backed insights on metabolism, GLP-1 science, and sustainable weight management — once a week.

No spam. Unsubscribe any time.